Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 2765940)

Published in Mol Cancer on October 01, 2009

Authors

Shan Wang1, Qian Liu, Ying Zhang, Ke Liu, Pengfei Yu, Kun Liu, Jinling Luan, Huiying Duan, Zhaoqiao Lu, Fengfei Wang, Erxi Wu, Kazumi Yagasaki, Guoying Zhang

Author Affiliations

1: Laboratory of Molecular Pharmacology, School of Pharmacy, Yantai University, Yantai, Shandong Province 264005, China. sw6262@yeah.net

Articles citing this

Chronic inflammation in cancer development. Front Immunol (2012) 1.14

Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology (2010) 1.09

Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells. Mol Oncol (2012) 1.02

Inhibitory effects of norcantharidin against human lung cancer cell growth and migration. Cytotechnology (2010) 1.02

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. Blood (2012) 1.02

Suppression of human lung cancer cell growth and migration by berbamine. Cytotechnology (2009) 0.96

SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Cancer Biol Ther (2010) 0.94

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer. Breast Cancer Res (2013) 0.92

Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action. Cytotechnology (2012) 0.92

Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II. Mol Cancer Ther (2013) 0.90

Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer (2010) 0.89

Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways. PLoS One (2014) 0.89

A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS One (2014) 0.89

Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis (2014) 0.87

Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action. Cytotechnology (2010) 0.82

Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives. Oncotarget (2014) 0.82

Inhibitory Effects of PC-SPESII Herbal Extract on Human Breast Cancer Metastasis. Evid Based Complement Alternat Med (2013) 0.81

A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling. Cancer Biol Ther (2013) 0.80

Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis. Mol Clin Oncol (2016) 0.78

3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells. J Nutr Biochem (2013) 0.78

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design. Future Med Chem (2012) 0.77

Suppression of proliferation and migration in highly-metastatic lung cancer cells as well as tumor growth by a new synthesized compound TBrC and its molecular mechanisms of action. Cytotechnology (2013) 0.76

Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. BMC Cancer (2015) 0.76

Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis. Prostate Cancer Prostatic Dis (2016) 0.75

Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia. J Zhejiang Univ Sci B (2012) 0.75

Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors. PLoS One (2015) 0.75

Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy. Cell Death Dis (2017) 0.75

1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and in vitro antiproliferative effect. Toxicol Rep (2015) 0.75

Structure-Based Target-Specific Screening Leads to Small-Molecule CaMKII Inhibitors. ChemMedChem (2017) 0.75

Articles cited by this

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32

Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (2001) 23.42

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48

Nuclear factor-kappaB: the enemy within. Cancer Cell (2004) 6.86

The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal (2002) 6.35

Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol (1998) 6.27

MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res (2009) 3.74

Tumours with PI3K activation are resistant to dietary restriction. Nature (2009) 3.60

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature (2002) 3.15

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res (2009) 3.11

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol (1999) 2.86

The role of PI3K in immune cells. Nat Immunol (2003) 2.41

The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci (2002) 2.37

Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med (2007) 2.37

Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34

Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res (2004) 2.32

Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol (2002) 2.04

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A (2003) 1.91

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem (2001) 1.74

Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol Pharmacol (2000) 1.59

Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene (2002) 1.58

Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem (2004) 1.56

Showering c-MET-dependent cancers with drugs. Curr Opin Genet Dev (2008) 1.52

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res (2006) 1.45

Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat (2002) 1.45

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer (2007) 1.40

NF- kappa B2/p100 induces Bcl-2 expression. Leukemia (2003) 1.39

Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem (2003) 1.34

Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology (2009) 1.34

Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst (2008) 1.32

Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr Cancer (2000) 1.28

Targeted therapy against Bcl-2-related proteins in breast cancer cells. Breast Cancer Res (2005) 1.27

Aetiology of cancer in Asia. Asian Pac J Cancer Prev (2008) 1.15

Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells. Cancer Biol Ther (2007) 1.14

Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma? Cancer Res (2009) 1.07

Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leuk Res (2005) 1.05

Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology (2009) 1.04

Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer (2007) 1.03

Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation. J Zhejiang Univ Sci B (2007) 0.98

In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs. Life Sci (1997) 0.89

Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. Chin Med J (Engl) (2007) 0.89

Angiogenic zip code. Nat Biotechnol (1999) 0.87

[The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine]. Zhonghua Yi Xue Za Zhi (2006) 0.85

The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer. BMC Cancer (2008) 0.80

Articles by these authors

(truncated to the top 100)

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12

HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69

Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol (2005) 6.47

Enhanced nitrogen deposition over China. Nature (2013) 5.49

A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res (2004) 5.21

Developmental fluoride neurotoxicity: a systematic review and meta-analysis. Environ Health Perspect (2012) 4.15

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science (2011) 4.13

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05

Nitrogen deposition and its ecological impact in China: an overview. Environ Pollut (2010) 4.03

Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res (2006) 3.83

One-year health care costs associated with delirium in the elderly population. Arch Intern Med (2008) 3.82

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res (2009) 3.57

PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest (2007) 3.54

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest (2006) 3.49

V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature (2006) 3.45

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology (2010) 3.37

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun (2004) 3.29

The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26

The draft genome of a diploid cotton Gossypium raimondii. Nat Genet (2012) 3.18

Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09

Crystal structure of a Rad51 filament. Nat Struct Mol Biol (2004) 2.83

HMGB1 promotes drug resistance in osteosarcoma. Cancer Res (2011) 2.82

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med (2005) 2.69

Proposed diagnostic criteria for internet addiction. Addiction (2010) 2.68

Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res (2009) 2.64

A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment method. J Am Geriatr Soc (2005) 2.63

Reporting in randomized trials published in International Journal of Cardiology in 2011 compared to the recommendations made in CONSORT 2010. Int J Cardiol (2012) 2.63

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension (2007) 2.62

Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62

Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis (2011) 2.59

Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A (2009) 2.59

Activity-independent homeostasis in rhythmically active neurons. Neuron (2003) 2.57

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res (2009) 2.54

Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc (2003) 2.53

Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev (2010) 2.53

Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis (2012) 2.49

Micro-optical sectioning tomography to obtain a high-resolution atlas of the mouse brain. Science (2010) 2.47

CutDB: a proteolytic event database. Nucleic Acids Res (2006) 2.41

Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells (2013) 2.40

Chromatin remodelers Isw1 and Chd1 maintain chromatin structure during transcription by preventing histone exchange. Nat Struct Mol Biol (2012) 2.37

Survival prediction of gastric cancer by a seven-microRNA signature. Gut (2009) 2.37

An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell (2013) 2.30

The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell (2006) 2.24

SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood (2008) 2.19

Flexible DNA bending in HU-DNA cocrystal structures. EMBO J (2003) 2.15

The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol (2011) 2.15

Retracted MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem (2007) 2.14

Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol (2007) 2.14

Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust (2008) 2.11

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res (2012) 2.10

Lack of association of ADH1C genotype with breast cancer susceptibility in Caucasian population: a pooled analysis of case-control studies. Breast (2012) 2.08

Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell (2006) 2.08

Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int (2005) 2.07

Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem (2005) 2.07

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation (2010) 2.07

MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05

Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02

Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One (2008) 2.01

miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res (2011) 2.00

Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy. J Crit Care (2007) 2.00

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A (2013) 1.95

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood (2008) 1.95

Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study. Diabetes (2013) 1.91

microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle (2010) 1.90

Life history response of Mediterranean fruit flies to dietary restriction. Aging Cell (2002) 1.89

A research algorithm to improve detection of delirium in the intensive care unit. Crit Care (2006) 1.89

DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem (2005) 1.89

Associations of processed meat and unprocessed red meat intake with incident diabetes: the Strong Heart Family Study. Am J Clin Nutr (2012) 1.88

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet (2012) 1.86

Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature (2005) 1.86

PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother (2007) 1.85

A regulatory protein that interferes with activator-stimulated transcription in bacteria. Proc Natl Acad Sci U S A (2003) 1.82

Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol (2011) 1.81

Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest (2009) 1.80

A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A (2004) 1.79

Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol (2007) 1.77

DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell Cycle (2009) 1.77

Interactive atrial neural network: Determining the connections between ganglionated plexi. Heart Rhythm (2006) 1.76

An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med (2014) 1.76

Drs2p-dependent formation of exocytic clathrin-coated vesicles in vivo. Curr Biol (2002) 1.75

Finding cis-regulatory elements using comparative genomics: some lessons from ENCODE data. Genome Res (2007) 1.75

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor. N Engl J Med (2015) 1.75

ABO3, a WRKY transcription factor, mediates plant responses to abscisic acid and drought tolerance in Arabidopsis. Plant J (2010) 1.74

Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J Proteome Res (2008) 1.73

Experimental validation of predicted mammalian erythroid cis-regulatory modules. Genome Res (2006) 1.71

Exo70 interacts with the Arp2/3 complex and regulates cell migration. Nat Cell Biol (2006) 1.70

Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol (2007) 1.70

Sleepiness, quality of life, and sleep maintenance in REM versus non-REM sleep-disordered breathing. Am J Respir Crit Care Med (2010) 1.69

A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc (2012) 1.69

Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Sci Transl Med (2012) 1.67

Symptoms of posttraumatic stress disorder, depression, and anxiety among adolescents following the 2008 Wenchuan earthquake in China. J Trauma Stress (2011) 1.66

The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood (2014) 1.66

Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples. Clin Chem (2006) 1.66

Intracranial self-administration of ethanol within the ventral tegmental area of male Wistar rats: evidence for involvement of dopamine neurons. J Neurosci (2004) 1.65

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood (2011) 1.65

DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J Neurosci (2004) 1.64